XRTX
Xortx Therapeutics Inc
NASDAQ · Pharmaceuticals
$0.40
0.00 (-0.69%)
Open$0.39
Previous Close$0.40
Day High$0.43
Day Low$0.38
52W High$47.00
52W Low$29.53
Volume—
Avg Volume111.5K
Market Cap5.71M
P/E Ratio19.03
EPS$1.78
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+10,549.4% upside
Current
$0.40
$0.40
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.23M | 1.25M | 1.18M |
| Net Income | 271.6K | 338.7K | 243.7K |
| Profit Margin | 22.1% | 27.0% | 20.7% |
| EBITDA | 408.7K | 499.5K | 428.0K |
| Free Cash Flow | 127.5K | 161.5K | 118.2K |
| Rev Growth | +6.1% | +20.7% | +12.6% |
| Debt/Equity | 0.69 | 0.65 | 0.58 |
Dividend
Dividend Yield2.55%
Annual Dividend$0.86
Payout Ratio48.6%
Frequencyquarterly
Ex-DividendMar 31, 2026
Pay DateApr 20, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |